SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

HeadTalks: Ask Us Anything: Expert Panel on Multiple Sclerosis

Event Time: Tuesday April 25, 2017 8:00 am to 9:00 am
Topic(s): MS and CNS Inflammatory Disease
Director(s): Dean Wingerchuk MD, FAAN, Benjamin Greenberg MD, FAAN, Aaron Miller MD, FAAN, Fred Lublin MD, FAAN
Description: Panel of experts field questions on Multiple Sclerosis.
Completion Message:
CME Credits: 0
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
8:00 AM - 9:00 AM HeadTalks: Ask Us Anything: Expert Panel on Multiple Sclerosis Benjamin Greenberg MD, FAAN, Fred Lublin MD, FAAN, Aaron Miller MD, FAAN, Dean Wingerchuk MD, FAAN 

Disclosures

Speaker Disclosure
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis, Alexion, EMD Serono. Dr. Greenberg has received research support from Genentech, Acorda, Medimmune, Chugai, MedDay.

Fred D. Lublin, MD, FAAN Dr. Lubin has received personal compensation for activities with Abbott, Acorda, Actelion, Allozyne, Avanir, Bayer HealthCare, Biogen Idec, Celgene, EMD Serono, Genmab, Johnson & Johnson, Medicinova, MorphoSys, Novartis, Pfizer, Questcor, Roche, Sanofi and Teva Neuros for consulting or serving on an advisory board. Dr. Lubin holds stock and/or stock options in Cognition Pharmaceuticals. Dr. Lubin has received research support from Acorda Therapeutics, Biogen Idec, Genzyme, National Institutes of Health, National MS Society, Novartis, Sanofi and Teva Neuroscience.

Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Accordant Health Services (Caremark), Adama, BiogenIdec, Celgene, Genzyme/Sanofi, Mallinckrodt, Mapi-Pharma, Novartis, Roche/Genentech. Dr. Miller has received personal compensation in an editorial capacity for Continuum Audio. Dr. Miller has received research support from BiogenIdec,Genzyme/sanofi, Mallickrodt, Novartis, Roche/Genentech, MedDay.

Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Caladrius and MedImmune. Dr. Wingerchuk has received personal compensation in an editorial capacity for The Neurologist.. Dr. Wingerchuk has received research support from Alexion and TerumoBCT.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C33 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
3:30 PM-5:30 PM
C57 Spanish: Update on MS Therapy Lilyana Amezcua MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C97 Multiple Sclerosis Overview I: Clinical Pearls John Corboy MD, FAAN
1:00 PM-3:00 PM
C107 Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
3:30 PM-5:30 PM
C121 Multiple Sclerosis Overview III: Basic and Translational Science Michael Racke MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C135 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C146 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
3:30 PM-5:30 PM
C161 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD

Thursday April 26, 2018

7:00 AM-9:00 AM
C174 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN

Friday April 27, 2018

1:00 PM-3:00 PM
C223 Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN

MEMBER LOG IN

Forgot Password?